BNC, the specialist bio-nanotechnology product development consultancy and the Nanotechnology Knowledge Transfer Network (NanoKTN), one of the UK's primary knowledge-based networks for Micro and Nanotechnologies, have delivered a highly successful conference in partnership with The Wellcome Trust.
Bio Nano Consulting (BNC), the specialist bio-nanotechnology product development consultancy and the Nanotechnology Knowledge Transfer Network (NanoKTN), one of the UK's primary knowledge-based networks for Micro and Nanotechnologies, have delivered a highly successful conference in partnership with The Wellcome Trust. The Nano 4 Life conference explored key areas within life sciences where nanotechnology offers opportunities to advance healthcare provision, improve
product development and help keep the UK a leading force in this exciting technology area. With high-quality keynote addresses from household names such as GSK, AstraZeneca and GE Healthcare, the event was significantly over-subscribed with greater than 170 registrations.
Nanotechnology is widely recognised to have the potential to make a significant impact on healthcare. This conference successfully brought together leading academic and industry researchers to discuss the increasingly important intersection between nanotechnology and the bio, pharma and healthcare sectors. As bio-nanotechnology experts, BNC organised the Nano 4 Life conference in order to explore how nanotechnology can further benefit life science.
Attendees of the conference heard where the technology can provide solutions to healthcare issues and also what researchers need to consider when developing innovations to ensure that companies can take these new ideas to the patients that need them. The conference had a very positive outlook on how the sector will be able to help solve some of the most pressing healthcare problems, such as drug resistant superbugs and major advances in cancer treatment.
Prof Leonard Fass, Visiting Professor at Imperial College London, one of the Nano 4 Life speakers commented, 'It was fantastic to see so many researchers from both academia and industry come together to discuss the applications of nanotechnology in healthcare and pharma.' He continued, 'What is more, attendance from such high-profile pharmaceutical companies has helped to highlight the importance of nanotechnology and how it can be used to advance today's life science sectors.'